The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Excedrin 250 mg/ 250 mg/ 65 mg film coated tablets



GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/122/001

Main Information

Trade NameExcedrin 250 mg/ 250 mg/ 65 mg film coated tablets
Active SubstancesAcetylsalicylic acid
Paracetamol
Caffeine
Dosage FormFilm-coated tablet
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/122/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

License statusAuthorised
Licence Issued04/06/2010
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceRetail sale through pharmacies only in packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. Packs containing more than 24 unit dosage forms are prescription only. Promotion to the general public for packs containing not more than 24 unit dosage forms. Promotion to healthcare professionals only for packs containing more than 24 unit dosage forms.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back